Bio-Path Holdings to Present at the BIO CEO & Investor Conference

Bio-Path Holdings Appoints Paul Aubert to its Board of Directors

Bio-Path Holdings Provides Clinical Update and 2018 Business Outlook

BIO-PATH HOLDINGS REPORTS THIRD QUARTER 2017 FINANCIAL RESULTS

Bio-Path Holdings Highlights Advancements in Preclinical Discovery Efforts

Bio-Path Holdings, Inc. Announces $4 Million Registered Direct Offering

Bio-Path Holdings to Announce Third Quarter 2017 Financial Results on November 10, 2017

Bio-Path Holdings to Present at the Rodman & Renshaw Annual Healthcare Conference

BIO-PATH HOLDINGS REPORTS SECOND QUARTER 2017 FINANCIAL RESULTS

Bio-Path Holdings to Announce Second Quarter 2017 Financial Results on August 10, 2017